Stay updated on LY2963016 vs Lantus in Chinese Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the LY2963016 vs Lantus in Chinese Type 2 Diabetes Clinical Trial page.

Latest updates to the LY2963016 vs Lantus in Chinese Type 2 Diabetes Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedAdded a dedicated Locations section with multiple Chinese provinces and cities (Anhui, Gansu, Guangdong, Henan, Hubei, Hunan, Jiangsu, Jilin, Liaoning, Ningxia, Shandong, Shanxi, Sichuan) and Nanjing, and updated the page to revision v3.3.3; removed the older HHS Vulnerability Disclosure and prior location sections.SummaryDifference1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedRevision: v3.3.2 is now displayed, replacing the previous v3.3.1 revision. This appears to be a minor site update with no changes to study details or navigation.SummaryDifference0.0%

- Check41 days agoChange DetectedSite revision updated to v3.3.1, replacing v3.2.0. This appears to be a platform update with no changes to the trial content or patient information.SummaryDifference0.0%

- Check48 days agoChange DetectedThe government funding notice that used to appear on the page has been removed; no new content was added. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check62 days agoChange DetectedNo substantive changes detected between the two screenshots. Differences are limited to minor layout and visual formatting variations.SummaryDifference0.4%

- Check91 days agoChange DetectedMajor update: page version bumped to v3.2.0 and a government funding operating-status notice added; previous v3.0.2 revision removed.SummaryDifference3%

Stay in the know with updates to LY2963016 vs Lantus in Chinese Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LY2963016 vs Lantus in Chinese Type 2 Diabetes Clinical Trial page.